Zdrowie i gospodarka · 08/04/2004

FDA Releases Revised Guidance on Changes to Approved NDAs or ANDAs

The Food and Drug Administration (FDA) has released a revised guidance document to help pharmaceutical companies report changes to their approved new drug applications (NDAs) or abbreviated new drug applications (ANDAs).